The drug is used to treat osteoporosis in postmenopausal women at high risk of a fracture or who have not responded to similar therapies.
Tymlos, an intravenous drug, carries a box warning over the risk of bone cancer.
More articles on supply chain:
FDA approves RFID device to locate breast lumps
9 strategies to lower drug costs, as ranked by public support
Poll: GOP prioritizes lower drug prices over reducing government’s role in healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
